A panel composed of medical and pharmacy directors expressed strong support for a greater role for cost-effectiveness analysis in US health policy decisions.
Schumarry Chao, MD, MBA
Advertisement
Articles by Schumarry Chao, MD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
2
GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis
3
Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year
4
Childhood Influenza Vaccine Rates Decreased From 2017 to 2023
5